• Home
  • About medac
  • Information for patients
  • Healthcare professionals
  • Products
  • Career opportunities
  • Media
  • NEW in the Haematology Portfolio: Carmustin Obvius

    With the launch of Carmustin Obvius in Germany, the Haematology Portfolio has been augmented by an additional substance.

    The active substance carmustine has been used in haematology and oncology for over 40 years.

    Carmustin Obvius is now available in Germany from medac.

    Nach oben